Compliance with coronavirus measures requires attention Compliance with coronavirus measures such as working from home, distancing and testing if you have symptoms decreased in the weeks leading up to the Cabinet’s recent press conference.
European project COHESIVE develops sustainable One Health approaches Today, fellow scientists and policymakers join the end symposium of the international project COHESIVE: One Health Structures in Europe.
More than health risks play a role in compliance with coronavirus measures The risk of COVID-19 is not the only factor that determines compliance with the coronavirus measures; other risks also play a role.
The 13-week scan now available for pregnant women Since 1 September, pregnant women in the Netherlands can have an early ultrasound scan to detect physical abnormalities in their unborn child: the 13-week scan.
Flu jab for additional groups The flu jab is offered free of charge every year to people aged 60 years and older, and to people who are at higher risk of becoming seriously ill from the flu virus due to medical reasons
Breast cancer screening resumes on Bonaire after COVID-19 hiatus Women aged 50 to 75 years on Bonaire can participate in the breast cancer screening programme again as of Wednesday, May 26, 2021. This was temporarily halted in 2020 due to the COVID-19 pandemic.
Policy on coronavirus measures causes friction, but compliance is still high for now Compliance with the coronavirus measures in the Netherlands, such as the night-time curfew, working from home and avoiding crowds, is still high.
Last winter’s flu epidemic was short and mild. And then COVID-19 arrived. The flu epidemic in the winter of 2019/2020 was mild and lasted only 5 weeks.
Compliance with coronavirus measures has improved Autumn 2020 saw a strong surge in the number of people who tested positive for COVID-19.
Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.